Abstract
The discovery of the involvement of nitric oxide (NO) in several physiological and pathophysiological processes launched a spectacular increase in studies in areas such as chemistry, biochemistry, and pharmacology. As a consequence, the development of NO donors or scavengers for regulation of its concentration and bioavailability in vivo is required. In this sense, ruthenium nitrosyl ammines and aliphatic tetraazamacrocyles have attracted a lot of attention due to their unique chemical properties. These complexes are water soluble and stable in solution, not to mention that they can deliver NO when photochemically or chemically activated by the reduction of the coordinated nitrosonium (NO+). The tuning of the energies of the charge transfer bands, the redox potential, and the specific rate constants of NO liberation, in both solution and matrices, is desirable for the achievement of selective NO delivery to biological targets, hence making the ruthenium ammines and aliphatic tetraazamacrocyles a quite versatile platform for biological application purposes. These ruthenium nitrosyls have shown to be active in firing neurons in mouse hippocampus, performing redox reactions in mitochondria, acting in blood pressure control, exhibiting cytotoxic activities against trypanosomatids (T.cruzi and L.major) and tumor cells. This tailoring approach is explored here, being heavily supported by the accumulated knowledge on the chemistry and photochemistry of ruthenium complexes, which allows NO donors/scavengers systems to be custom made designed.
Keywords: Ruthenium, nitrosyls, nitric oxide carriers, biological applications, ruthenium nitrosyl ammines, aliphatic tetraazamacrocyles, performing redox reactions, neurotransmission, pathogens killing, N-hydroxyguanidines, pseudo-octahedral complexes, trypanosomatids, photodynamic therapy (PDT), Mouse Hippocampus, iron-cluster-containing, differential pulse polarography (DPP), mitochondrial permeability transition (MPT), HepG2 cells, Hipotensive Properties, nitric oxide synthase enzyme (NOS), ali-phatic tetraazamacrocyles, Bioavailability, Biodistribution, Toxicity, Antiparasitic Effects, mac = macrocyclic ligand, nic = nicotinamide, NRU = neutral red uptake, P(OEt)3 = triethylphosphite, PAMAM = polyamidoamine dendrimers, RCR = respiratory control ratio, T. cruzi = Trypanosoma cruzi, TI = therapeutic, = quantum yield of release of NO
Current Medicinal Chemistry
Title: Tailoring NO Donors Metallopharmaceuticals: Ruthenium Nitrosyl Ammines and Aliphatic Tetraazamacrocycles
Volume: 17 Issue: 31
Author(s): E. Tfouni, F G. Doro, L. E. Figueiredo, J. C.M. Pereira, G. Metzker and D. W. Franco
Affiliation:
Keywords: Ruthenium, nitrosyls, nitric oxide carriers, biological applications, ruthenium nitrosyl ammines, aliphatic tetraazamacrocyles, performing redox reactions, neurotransmission, pathogens killing, N-hydroxyguanidines, pseudo-octahedral complexes, trypanosomatids, photodynamic therapy (PDT), Mouse Hippocampus, iron-cluster-containing, differential pulse polarography (DPP), mitochondrial permeability transition (MPT), HepG2 cells, Hipotensive Properties, nitric oxide synthase enzyme (NOS), ali-phatic tetraazamacrocyles, Bioavailability, Biodistribution, Toxicity, Antiparasitic Effects, mac = macrocyclic ligand, nic = nicotinamide, NRU = neutral red uptake, P(OEt)3 = triethylphosphite, PAMAM = polyamidoamine dendrimers, RCR = respiratory control ratio, T. cruzi = Trypanosoma cruzi, TI = therapeutic, = quantum yield of release of NO
Abstract: The discovery of the involvement of nitric oxide (NO) in several physiological and pathophysiological processes launched a spectacular increase in studies in areas such as chemistry, biochemistry, and pharmacology. As a consequence, the development of NO donors or scavengers for regulation of its concentration and bioavailability in vivo is required. In this sense, ruthenium nitrosyl ammines and aliphatic tetraazamacrocyles have attracted a lot of attention due to their unique chemical properties. These complexes are water soluble and stable in solution, not to mention that they can deliver NO when photochemically or chemically activated by the reduction of the coordinated nitrosonium (NO+). The tuning of the energies of the charge transfer bands, the redox potential, and the specific rate constants of NO liberation, in both solution and matrices, is desirable for the achievement of selective NO delivery to biological targets, hence making the ruthenium ammines and aliphatic tetraazamacrocyles a quite versatile platform for biological application purposes. These ruthenium nitrosyls have shown to be active in firing neurons in mouse hippocampus, performing redox reactions in mitochondria, acting in blood pressure control, exhibiting cytotoxic activities against trypanosomatids (T.cruzi and L.major) and tumor cells. This tailoring approach is explored here, being heavily supported by the accumulated knowledge on the chemistry and photochemistry of ruthenium complexes, which allows NO donors/scavengers systems to be custom made designed.
Export Options
About this article
Cite this article as:
Tfouni E., G. Doro F, E. Figueiredo L., C.M. Pereira J., Metzker G. and W. Franco D., Tailoring NO Donors Metallopharmaceuticals: Ruthenium Nitrosyl Ammines and Aliphatic Tetraazamacrocycles, Current Medicinal Chemistry 2010; 17 (31) . https://dx.doi.org/10.2174/092986710793213788
DOI https://dx.doi.org/10.2174/092986710793213788 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Renal Effects of Empagliflozin in Patients with Type 2 Diabetes
Mellitus
Current Medicinal Chemistry Optimising the Use of Non-Invasive Ventilation in the Intensive Care Setting
Current Respiratory Medicine Reviews Prevention of Preterm Labor by Isosorbide Dinitrate and Nitroglycerin Patch
Cardiovascular & Hematological Disorders-Drug Targets Nociceptin/Orphanin FQ Peptide Receptors: Pharmacology and Clinical Implications
Current Drug Targets Altered CYP Expression and Function in Response to Dietary Factors: Potential Roles in Disease Pathogenesis
Current Drug Metabolism Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery Anorexia Nervosa and the Use of Total Parenteral Nutrition Refeeding
Current Nutrition & Food Science Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future
Current Pharmaceutical Design B-Type Natriuretic Peptide: Endogenous Regulator of Myocardial Structure, Biomarker and Therapeutic Target
Current Molecular Medicine “Vascular Incontinence” and Normal-Pressure Hydrocephalus: Two Commonsources of Elderly Incontinence with Brain Etiologies
Current Drug Therapy Regulation of Adrenomedullin and its Family Peptide by RAMP System – Lessons from Genetically Engineered Mice
Current Protein & Peptide Science When and How Should We Cover Patients for Community-Acquired Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia?
Current Respiratory Medicine Reviews Matrix Metalloproteinases as Drug Targets in Acute Pulmonary Embolism
Current Drug Targets Thyroid Hormones and Cardiovascular System: From Bench to Bedside
Current Drug Therapy The Use of Antidepressants for Physical and Psychological Symptoms in Cancer
Current Drug Targets Genetics and Personalized Medicine in Antidepressant Treatment
Current Pharmaceutical Design Immune Response Towards Snake Venoms
Inflammation & Allergy - Drug Targets (Discontinued) The RNA-Dependent-RNA Polymerase, an Emerging Antiviral Drug Target for the Hendra Virus
Current Drug Targets Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Current Cancer Drug Targets <i>Valeriana spp</i>.: Biological Activities and New <i>In vitro</i> and <i>In vivo</i> Perspectives
Current Bioactive Compounds